scholarly journals Pulmonary arterial hypertension: achievements and realities of modern treatment, a look into the future

2021 ◽  
Vol 93 (9) ◽  
pp. 1009-1017
Author(s):  
Tamila V. Martynyuk ◽  
Irina E. Chazova
Keyword(s):  
Pulmonary Arterial Hypertension ◽  
Risk Stratification ◽  
Arterial Hypertension ◽  
Specific Therapy ◽  
The Future ◽  
Pulmonary Arterial ◽  
Coronavirus Infection ◽  
Modern Treatment ◽  
Switching Strategies

The paper summarizes the most important aspects of modern treatment of patients with pulmonary arterial hypertension (PAH): the goals of therapy are indicated, the issues of risk stratification of PAH progression/mortality, the place of combination specific therapy and switching strategies are considered, as well as new promising approaches to therapy; features of the course of the new coronavirus infection COVID-19 in this category of patients are discussed.

scholarly journals Risk stratification methods and their significance in pulmonary arterial hypertension

2019 ◽  
Vol 91 (9) ◽  
pp. 150-157
Author(s):  
S N Avdeev ◽  
N A Tsareva
Keyword(s):  
Pulmonary Arterial Hypertension ◽  
Risk Stratification ◽  
Arterial Hypertension ◽  
Poor Prognosis ◽  
Progressive Disease ◽  
Response To Therapy ◽  
Specific Therapy ◽  
Pulmonary Arterial ◽  
Current Guidelines ◽  
Choice Of Therapy

Despite significant advances in therapy, pulmonary arterial hypertension (PAH) remains a progressive disease with a poor prognosis. Immediately after establishing the diagnosis of PAH, urgent treatment with PAH-specific therapy is required. Due to the progressive nature of the disease, all patients should be closely monitored and their treatment regimen should be promptly changed according to clinical need. Risk stratification is an important method for informing the clinician and the patient about the prognosis of disease and the choice of therapy methods. The REVEAL scale and the ESC/ERS 2015 risk assessment table are important multifactorial tools for making decisions about the prescription and correction of PAH therapy, as well as for assessment of patients' response to therapy. Current guidelines for PAH indicate that the most important task of treatment of PAH is to achieve the low - risk status.

Prognostic Value of Early Risk Stratification in Pediatric Pulmonary Arterial Hypertension

2021 ◽  
Author(s):  
László Ablonczy ◽  
Tamás Ferenci ◽  
Orsolya Somoskövi ◽  
Réka Osváth ◽  
György S. Reusz ◽  
...  
Keyword(s):  
Pulmonary Arterial Hypertension ◽  
Risk Stratification ◽  
Arterial Hypertension ◽  
Prognostic Value ◽  
Early Risk ◽  
Pulmonary Arterial

scholarly journals Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation

2009 ◽  
Vol 35 (5) ◽  
pp. 1079-1087 ◽  
Author(s):  
T. Thenappan ◽  
S. J. Shah ◽  
S. Rich ◽  
L. Tian ◽  
S. L. Archer ◽  
...  
Keyword(s):  
Pulmonary Arterial Hypertension ◽  
Risk Stratification ◽  
Arterial Hypertension ◽  
Pulmonary Arterial

scholarly journals Right Ventricular Index for Risk Stratification of Patients with Pulmonary Arterial Hypertension

Respiration ◽  
2018 ◽  
Vol 96 (3) ◽  
pp. 249-258 ◽  
Author(s):  
Christoph Sinning ◽  
Lars Harbaum ◽  
Benedikt Schrage ◽  
Nicole Rübsamen ◽  
Christina Magnussen ◽  
...  
Keyword(s):  
Pulmonary Arterial Hypertension ◽  
Risk Stratification ◽  
Arterial Hypertension ◽  
Right Ventricular ◽  
Pulmonary Arterial
Sign in / Sign up

Export Citation Format

Share Document